Official matched intervention · Drug

Copaxone®, clinical trials

2 selected ClinicalTrials.gov records carrying the official matched intervention Copaxone®, (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.

Registry records

2 selected records.

Connected peptides

1 profiles.

Source boundary

ClinicalTrials.gov intervention field.

Cross-source journeys

Explore connected peptide records

Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 11 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.

Collection change ledger

Recently changed records on this intervention hub

All recent changes →

These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.

Record added

ClinicalTrials.gov record NCT01216072

PeptideScanner retained ClinicalTrials.gov record NCT01216072 at 2026-11-16T17:42:50.457Z. Its registry update date was 2014-02-10, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

PeptideScanner change date
November 16, 2026
Cited source date
February 10, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01317004

PeptideScanner retained ClinicalTrials.gov record NCT01317004 at 2026-11-16T17:42:50.457Z. Its registry update date was 2015-06-22, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

PeptideScanner change date
November 16, 2026
Cited source date
June 22, 2015
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →